CBR4 blocking peptide product blog
Tags: CBR4; Blocking Peptide; CBR4 blocking peptide;
The CBR4 cbr4 (Catalog #MBS9222636) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.The CBR4 cbr4 product has the following accession number(s) (GI #269849708) (NCBI Accession #Q8N4T8.3) (Uniprot Accession #Q8N4T8). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
The heteroteramer with HSD17B8 has NADH-dependent 3- ketoacyl-acyl carrier protein reductase activity. May play a role in biosynthesis of fatty acids in mitochondria. The homotetramer may act as NADPH-dependent quinone reductase. Has broad substrate specificity and reduces 9,10-phenanthrenequinone, 1,4-benzoquinone and various other o-quinones and p-quinones (in vitro).
Cellular Location: Mitochondrion matrix. Tissue Location: Detected in liver and kidney (at protein level). Fibrosis, Vascular Diseases are some of the diseases may be linked to CBR4 Antibody (C-term) Blocking Peptide. CBR4 also interacts with the following gene(s): CBR1, CBR3. Blood, Kidney, Liver, Muscle, Prostate, Uterus, Vascular tissues are correlated with this protein.